Previous 10 | Next 10 |
Endo International (NASDAQ: ENDP) , a specialty pharmaceutical company, saw its shares fall 69% on Wednesday. The stock closed at $1.16 on Tuesday then opened at $1.13 on Wednesday. Shortly after noon on Wednesday, it descended rapidly to $0.3615 a share, its 52-week low. The stock'...
Gainers: DLocal Limited (DLO) +24%. Kidpik (PIK) +21%. GreenBox (GBOX) +19%. Sunlands Technology Group (STG) +17%. TDCX (TDCX) +15%. Magnachip Semiconductor (MX) +14%. Concert Pharmaceuticals (CNCE) +13%. Agilysys (AGYS) +13%. Youdao (DAO) +12%. Losers: Endo International plc (ENDP) -53%. Bau...
Endo International (NASDAQ:ENDP) has begun negotiations with its lenders and senior bondholders seeking a possible reorganization of more than $8 billion of its debt, The Wall Street Journal reported on Wednesday citing people familiar with the matter. The lawyers representing lenders have al...
Larry Robbins and Mark Horowitz owned fund, Glenview Capital in its recent 13F filing disclosed newly acquired stakes in Valvoline (VVV) with 1.7M shares, Berkeley Lights (BLI) with 1.19M shares, Las Vegas Sands (LVS) with 1M shares, Meta Platforms (FB) with 0.08M shares. The fund exited posi...
Second quarter guidance implies catastrophic sales and margins from Vasostrict. Bonds plummeted implying first lien debt might be impaired. Possibly impairment of first lien debt and near certain impairment of second lien debt means zero equity value. Bankruptcy filing should ...
Endo International (NASDAQ:ENDP -19.0%) price target cut to $2 from $4 by BMO Capital Markets analyst Gary Nachman, maintains market perform rating. This implyies a 41% increase from last price. Company reported earnings and sales that topped estimates for the quarter on M...
Piper Sandler has downgraded the Ireland-based drugmaker Endo International (NASDAQ:ENDP) to Underweight from Neutral, noting the impact of generic competition on the company’s vasopressin injection, Vasostrict. With its 1Q 2022 financials on Thursday, Endo (ENDP) reported a ~30% YoY r...
Endo International (NASDAQ: ENDP) stock was cratering on Friday, with shares falling 31.6% as of 11:49 a.m. ET. The sharp sell-off came after the drugmaker announced its first-quarter results following the market close on Thursday. The company reported Q1 net revenue of $652.3 m...
Endo International plc (ENDP) Q1 2022 Earnings Conference Call May 6, 2022 07:30 ET Company Participants Laure Park - Senior Vice President, Investor Relations and Corporate Affairs Blaise Coleman - President and Chief Executive Officer Mark Bradley - Executive right Vice President and Chief ...
Gainers: ChemoCentryx (CCXI) +19%. iRhythm Technologies (IRTC) +16%. Jounce Therapeutics (JNCE) +15%. Grifols (GRFS) +9%. Sensus Healthcare (SRTS) +8%. Losers: Joint (JYNT) -46%. Endo International (ENDP) -34%. Guardant Health (GH) -26%. Gain ...
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...